Shareholder Information

Download Documentation Investor Presentation
Webcast ImageWebcast - Replay
Q3 2014 Cambrex Earnings Conference Call
10/30/14 at 8:30 a.m. ET
Webcast ImageWebcast - Replay
Cambrex at Rodman & Renshaw Global Investment Conference
09/10/14 at 1:15 p.m. ET

About Cambrex

Cambrex Corporation is a custom development and manufacturing organization that specializes in products and services that accelerate the development and commercialization of small molecule therapeutics.

We offer APIs, advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals.

Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage forms.

Stock Quote

CBM (Common Stock)
ExchangeNYSE (US Dollar)
Price$23.27
Change (%) Stock is Up 0.18 (0.78%)
Volume131,556
Data as of 11/25/14 4:04 p.m. ET
Minimum 20 minute delay
Refresh quote

Stock Chart

Stock chart for: 03NA000000CBM

Recent News more

10/30/14 - 7:01 a.m.
Cambrex Reports Third Quarter 2014 Financial Results
 
10/28/14 - 3:03 p.m.
Cambrex to Announce Third Quarter 2014 Financial Results on October 30, 2014
 
10/02/14 - 2:33 p.m.
Cambrex to Exhibit at the 2014 AAPS Annual Meeting and Exposition
 
09/26/14 - 1:34 p.m.
Cambrex to Present Webinar on Managing the API Life Cycle
 

Upcoming Eventsmore

There are currently no events scheduled.

Contact Information

Stephanie LaFiura
Investors Relations Associate
Phone: 201-804-3037
Fax: 201-804-9852
Email: stephanie.lafiura@cambrex.com

American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
Phone: 718.921.8275
Fax: 718.921.8331
Email: cpino@amstock.com



Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.